Logo image of ZNTE

ZANITE ACQUISITION CORP-CL A (ZNTE) Stock Fundamental Analysis

NASDAQ:ZNTE - Nasdaq - US98907K1034 - Common Stock

11.32  +1.16 (+11.42%)

After market: 11.3 -0.02 (-0.18%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ZNTE. ZNTE was compared to 0 industry peers in the Unkown industry. ZNTE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ZNTE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ZNTE had positive earnings in the past year.
ZNTE Yearly Net Income VS EBIT VS OCF VS FCFZNTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 0 5M -5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 6.12%
ROE 7.22%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZNTE Yearly ROA, ROE, ROICZNTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 2 -2 4 6

1.3 Margins

ZNTE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZNTE Yearly Profit, Operating, Gross MarginsZNTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for ZNTE remains at a similar level compared to 1 year ago.
ZNTE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ZNTE Yearly Shares OutstandingZNTE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 5M 10M 15M 20M 25M
ZNTE Yearly Total Debt VS Total AssetsZNTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 50M 100M 150M 200M

2.2 Solvency

ZNTE has an Altman-Z score of 49.05. This indicates that ZNTE is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for ZNTE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 49.05
ROIC/WACCN/A
WACCN/A
ZNTE Yearly LT Debt VS Equity VS FCFZNTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 50M 100M 150M 200M

2.3 Liquidity

ZNTE has a Current Ratio of 0.12. This is a bad value and indicates that ZNTE is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.12 indicates that ZNTE may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
ZNTE Yearly Current Assets VS Current LiabilitesZNTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 1M 2M 3M 4M

More info and screens

1

3. Growth

3.1 Past

ZNTE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4170.65%, which is quite impressive.
EPS 1Y (TTM)4170.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-853.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZNTE Yearly Revenue VS EstimatesZNTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021
ZNTE Yearly EPS VS EstimatesZNTE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 22.20, the valuation of ZNTE can be described as rather expensive.
The average S&P500 Price/Earnings ratio is at 29.53. ZNTE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 22.2
Fwd PE N/A
ZNTE Price Earnings VS Forward Price EarningsZNTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZNTE Per share dataZNTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ZNTE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZANITE ACQUISITION CORP-CL A

NASDAQ:ZNTE (5/9/2022, 8:00:13 PM)

After market: 11.3 -0.02 (-0.18%)

11.32

+1.16 (+11.42%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.18%
Inst Owner Change0%
Ins Owners1.73%
Ins Owner Change0%
Market Cap2.99B
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.2
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 14.88
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.51
EY4.51%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.76
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.12%
ROE 7.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z 49.05
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4170.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-853.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A